Jordi Vila, MD
Head of the Department of Clinical Microbiology in the Hospital Clinic and Full Professor, Department of Microbiology, School of Medicine, University of Barcelona. Additionally, he is a Research Professor at the Institute of Global Health of Barcelona (ISGlobal).
He obtained a specialty in clinical microbiology in 1984 and a PhD in Biochemistry in 1985. His areas of research focus include an investigation of the molecular bases of antimicrobial resistance, mainly in multidrug-resistant Gram-negative bacteria such as Acinetobacter baumannii, Pseudomonas aeruginosa and multidrug-resistant Enterobacteriaceae, as well as the discovery of new drugs against bacteria. He is currently working on a new derivative of ciprofloxacin with good activity against multidrug-resistant Gram-negative bacilli.
He has published 238 articles in peer-reviewed journals, 35 book chapters, and directed 11 doctoral thesis.